Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06892353

AI-Powered DIY Screening System for Diabetic Retinopathy

A pragmatic trial will be conducted in two representative clinics in each of the three types of targeted settings. It will be run for 3 months in each clinic to complete data collection of up to 100 patients in SPGC and Optometry Clinics, 200 at GPGC and 200 in GOPC in total. All the subjects will conduct a DIY screening, physician consultation, survey with questionnaires and a phone interview three months after their baseline assessment. This study will assess automated screening in terms of success rate of the DIY system without active assistant help, accuracy, screening rate and detection rate, adherence to referral and experience of participants, as well as cost-effectiveness in real-world settings.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • subjects who are 50 years of age or older, or subjects who are 18 years of age or older and have diabetes, and
  • have not undertaken an eye examination in the previous 12 months (elevated risk of undiagnosed disease).
  • Provide written informed consent.

Exclusion criteria

  • individuals with physical disabilities that prevent the use of a fundus camera, or
  • individuals with speech impairments who are unable to complete telephone follow-ups.

Treatment and study plan

AI-powered fundus camera screening

Diagnostic Test

All the participants will undertake an AI-powered fundus camera screening, physician/optometrist consultation, survey with questionnaires and a phone interview three months after their baseline assessment.

Primary outcomes

  1. Success Rate without Active Assistant Help

    Time frame: 3 months

    Success rate of using the DIY screening booth help will be determined by the number of successful screening runs without active assistant help divided by the total number of screening runs.

Secondary outcomes

  1. Assessment of Consumer Acceptability

    Time frame: 3 months

    Assessment of consumer acceptability will be determined by the positive response rate/screening rate (i.e. the total number of eligible patients who agree to screening (numerator) divided by the total number of eligible individuals (denominator)).

  2. Diagnostic Accuracy

    Time frame: 3 months

    All retinal images will be re-graded by two independent ophthalmologists, with any disagreements adjudicated by a third ophthalmologist (gold standard). This grading result will be considered as gold standard reference for the diagnostic accuracy of the automated screening. The indicators for diagnostic accuracy include: sensitivity.

  3. Disease Detection Rates

    Time frame: 3 months

    The detection rate is defined as the proportion of newly diagnosed DR cases divided by the total number of eligible individuals.

  4. Adherence to Referral

    Time frame: 3 months

    Patient adherence to referral will be measured as the proportion of patients who attend an ophthalmology service among the total number of referred patients.

  5. Technical Feasibility: Quality of Image Acquisition

    Time frame: 3 months

    The investigators will use a standardized checklist to assess the quality of images acquired during the study. This checklist will include criteria resolution, clarity, and completeness of the images. A sample of images will be reviewed by a panel of experts to ensure consistency and reliability in the assessment.

  6. Cost-effectiveness of DIY Screening

    Time frame: 3 months

    The cost-effective analyses will involve using the incremental cost-effectiveness ratio (ICER) as the key indicator to identify whether DIY screening model is a good investment.

  7. Assessment of Consumer Satisfaction

    Time frame: 3 months

    The responses to the 5-point Likert scale question will be analysed using the "document variable statistics" function in MAXQDA software. Data from the open-ended questionnaire will be analysed thematically. All themed information will be shared for review by project steering committee. The Likert scale ranges from 1 to 5. The content includes 5 options, including strongly disagree, disagree, neural, agree, strongly agree. The higher scores (e.g., 4 or 5) indicate a stronger agreement or a more positive attitude towards the statement, while lower scores (e.g., 1 or 2) indicate disagreement or a more negative attitude.

  8. Diagnostic Accuracy

    Time frame: 3 months

    All retinal images will be re-graded by two independent ophthalmologists, with any disagreements adjudicated by a third ophthalmologist (gold standard). This grading result will be considered as gold standard reference for the diagnostic accuracy of the automated screening. The indicators for diagnostic accuracy include: specificity.

  9. Diagnostic Accuracy

    Time frame: 3 months

    All retinal images will be re-graded by two independent ophthalmologists, with any disagreements adjudicated by a third ophthalmologist (gold standard). This grading result will be considered as gold standard reference for the diagnostic accuracy of the automated screening. The indicators for diagnostic accuracy include: accuracy.

  10. Diagnostic Accuracy

    Time frame: 3 months

    All retinal images will be re-graded by two independent ophthalmologists, with any disagreements adjudicated by a third ophthalmologist (gold standard). This grading result will be considered as gold standard reference for the diagnostic accuracy of the automated screening. The indicators for diagnostic accuracy include: positive/negative predictive values.

  11. Diagnostic Accuracy

    Time frame: 3 months

    All retinal images will be re-graded by two independent ophthalmologists, with any disagreements adjudicated by a third ophthalmologist (gold standard). This grading result will be considered as gold standard reference for the diagnostic accuracy of the automated screening. The indicators for diagnostic accuracy include: area under curve.

  12. Technical Feasibility:The duration of Clinic Flow

    Time frame: 3 months

    The investigators will conduct time-motion studies to evaluate the impact of the new imaging process on clinic flow. This will track the time taken for image acquisition, processing, and reporting and record the total time spent.

  13. Technical Feasibility:Reporting and Impact on Clinic Flow

    Time frame: 3 months

    The investigators will involve track any delays or disruptions in the clinic schedule.

  14. Technical Feasibility: The type of technical error

    Time frame: 3 months

    The investigators will maintain a log of technical errors encountered during the image acquisition process. This log will include the type of error.

  15. Technical Feasibility: Number of Recorded Technical Errors

    Time frame: 3 months

    The investigators will maintain a log of technical errors encountered during the image acquisition process. This log will record the frequency of each type of technical errors.

  16. Technical Feasibility: Remedies for technical errors

    Time frame: 3 months

    The investigators will maintain a log of technical errors encountered during the image acquisition process. This log will document any corrective actions taken in response to technical errors. Regular review meetings will be held to analyze these errors and implement strategies to minimize their occurrence.

Study contacts

Contact information is provided by the study sponsor or research team.

Mingguang He

CONTACT

[email protected]

85234002795

Yanxian Chen

CONTACT

[email protected]

85227666111

Sponsors and collaborators

Lead sponsor

The Hong Kong Polytechnic University

Other

Registry information

Official study title

AI-powered Low-cost Portable Fundus Camera to Deliver Diabetic Retinopathy Screening At Primary Health Care Setting: a Pragmatic Trial

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Mar 24, 2025
Registry last updated
Mar 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.